The promise of melanoma vaccines: A new hope for skin cancer?
Discover how melanoma vaccines are gaining traction in the clinic and could soon become a treatment option for this deadly skin cancer.| Labiotech.eu
As September marks the beginning of Blood Cancer Awareness Month, delve into what is being developed in the biotech pipelines. The post Blood Cancer Awareness Month: What biotech holds in store appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to ...| Labiotech.eu
Artificial intelligence (AI) is increasingly helping drive advances in science and medicine — including cellular signaling. In a recent study, ...Read More The post AI-designed proteins open doors to new immunotherapies appeared first on Boston Children's Answers.| Boston Children's Answers
Imagine your immune cells could be modified to attack any kind of cancer. T cell receptor (TCR) therapy has the potential to one day become a universal cancer treatment. But there are risks. Similarities between cancerous and healthy cells can affect the body’s immune response, causing T cells to attack unintended targets. TCR therapy needs... The post BATMAN brings TCR therapy out of the shadows appeared first on Cold Spring Harbor Laboratory.| Cold Spring Harbor Laboratory
Bispecific antibodies (BsAbs) are redefining the landscape of therapeutic design, offering dual-target precision that conventional antibodies can’t match. These specially engineered antibodies bind to either two different antigens or two distinct sites on the same antigen. BsAbs form a powerful new class of therapy which has caused excitement among the drug development community due to… The post Bispecific antibodies: The next generation of precision therapeutics appeared first on Drug ...| Drug Discovery and Development
Discover how melanoma vaccines are gaining traction in the clinic and could soon become a treatment option for this deadly skin cancer.| Labiotech.eu
Drs. Jianping Huang and John Ligon have launched a human clinical trial to test an immunotherapy treatment for children with high-grade gliomas.| McKnight Brain Institute » University of Florida
One dose of a new treatment, delivered by nasal spray, clears away build-ups of the toxic tau protein associated with Alzheimer’s disease from inside brain cells, improving memory, according to new research. It paves the way for new treatments for the debilitating disease.| New Atlas
Essential to Chen’s study is a foundational understanding of the tumor microenvironment (TME) and tumor-associated macrophages (TAMs). The TME, comprising various immune cells, plays a crucial role in shaping an immunosuppressive landscape that promotes tumor development, progression, metastasis, and resistance to therapy. Among the immune cells in the TME, TAMs are the most abundant and are known to exert potent immunosuppressive functions, supporting tumor growth, and immune evasion.| Cancer Center at Illinois
A new form of immunotherapy helps immune cells “armor” themselves against exhaustion by releasing their own medicine to keep them going in the fight against cancer. In a small ongoing trial, 100% of patients have achieved complete remission, and the new method is faster and cheaper to produce than…| New Atlas
Taking inspiration from the CAR T-cell technology used to provide personalized cancer treatments, researchers have conducted a proof-of-concept study showing how similar compounds can precisely target protein tangles and plaques in the brain.| New Atlas
Introduction – World Brain Tumor Day will be celebrated annually on June 8 across the world to raise awareness about the harmful effects of brain tumors and also provide support to those patie…| daneelyunus
Representing the creative, outside-the-box thinking done by the program’s namesake, two College of Medicine members received the 2025 Thomas H. Maren Research Excellence Award for their innovative biomedical ideas.| research.med.ufl.edu
Investigators from Nationwide Children’s Hospital created fratricide-resistant and metabolically-enhanced chimeric antigen receptor (CAR) natural killer (NK) and T cells that have cytotoxic effects on many hematologic tumors.| Pediatrics Nationwide
When Siana learned she had breast cancer, her world stopped. She was angry and scared, but realized she needed to focus on the positive.| Susan G. Komen®
Skin prick allergy testing requires specialized training to administer and interpret the tests and determine appropriate treatment.| Allergy & Asthma Network
The emerging spatial transcriptomics field is letting researchers map out gene expression in tumor and brain samples. How could this change the way we treat disease?| Labiotech.eu
The fight against cancer is an arms race, and one of the most effective weapons in clinicians’ arsenals is immunotherapy. Immune checkpoint therapy has become the standard for treating several types of cancer. However, the Nobel Prize-winning strategy is ineffective for most pancreatic ductal adenocarcinoma (PDAC) patients. “Immune checkpoint therapy is only an option in...| Cold Spring Harbor Laboratory
A new oral desensitization treatment for children with peanut allergies is on the cusp of FDA approval, however questions remain over both the long-term efficacy of the treatment and the ultimate cost for something that is essentially not much different to peanut flour in a capsule.| New Atlas
On its way to tackle cancer therapy resistance with its monoclonal antibody visugromab, CataLym completes a $150 million series D round.| Labiotech.eu
An mRNA cancer vaccine developed at the University of Florida has attracted widespread news coverage.| cancer.ufl.edu
Carolina researchers are using CAR-T cells to create better and personalized cancer treatments in one of the largest cell therapy facilities on the East Coast.| UNC Research Stories
